天大药业有限公司（00455）于2026年3月3日公布截至2026年2月28日的股份变动月报表。公告显示，公司截至报告期末的注册股本总额维持在4,000,000,000股普通股，面值每股0.1港元，对应注册股本为4亿港元；已发行股份数量保持在2,150,041,884股，未见新增发行、购回或注销，亦未记录任何库存股份变动。
此外，公司透露，现行的购股权计划总授予股份期权数量为215,004,188股。本月内并无行使期权增发或转让库藏股份的活动。公司确认已满足有关公众持股量的最低要求。
该公告由董事吕文生签署。公司表示将继续遵守香港联合交易所有限公司《上市规则》的各项规定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.